- BySeeking Alpha-
Investing.com – U.S. equities were higher at the close on Thursday, as gains in the Technology, Healthcare and Consumer Services sectors propelled shares higher. At the close in...
Immunoprecise Antibodies Ltd (NASDAQ: IPA) has announced new results from its TATX-03 PolyTope Therapy, demonstrating potent pseudovirus neutralizing activity against the...
ImmunoPrecise Antibodies Ltd. is a technology platform company that supports pharmaceutical and biotechnology companies. The Company discover, develop, engineer and manufacture therapeutic antibodies against all classes of disease targets. The Company transforms the conventional multi-vendor antibody discovery model by providing a suite of services tailored to improve antibody genetic diversity and epitope coverage, to discover antibodies against rare epitopes. The Company offers support to its partners with customized, computational project design, antigen preparation, an on-site vivarium, immunization services, discovery platforms, functional antibody testing, lead candidate selection, antibody optimization, antibody engineering and manufacturing. The Company’s services include B cell sorting, phage display, abthena bispecifics, LucinaTech Humanization, affinity maturation, immunization, hybridoma, sequencing and cell line development.